ICAM1 and neoplasm: The anti-tumor activity of two ADCs was also determined by weighing the tumor mass at the end point, and the inhibitory efficiency of tumor weight by ICAM1-DXd and ICAM1-MMAE were 59% and 53% of PBS, respectively (Fig. 5d).